Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for other antibody patents approaching the end of their term.
The global...
Federal Court dismisses Sanofi’s appeal and orders that Amgen’s Repatha patent applications proceed to grant, offering key lessons for...